Application no. and date | 11793928.0 (espacenet) (Federated) (European Patent Register), 20111122 | Patent/reg. no. and date | DK/EP 2642999, 20160928 | Publication date | 20131002 | Priority no. and date | US 416689 P, 20101123 | EP pub. no. and date |
EP 2642999 20131002 | Effective date | | Applicant/owner | AbbVie Ireland Unlimited Company, 70 Sir John Rogerson's Quay Dublin 2, IE | Applicant ref. no. | P018891EPDK1 | Inventor | GHAYUR, Tariq, 1014 Washington Street
Holliston, Massachusetts 01746, US, ELMORE, Steven, 2139 Ash Lane
Northbrook, Illinois 60062, US, SOUERS, Andrew, 901 Hinman Apt. 3a
Evanston, Illinois 60202, US, WANG, Li Chun, 177 Old Westboro Road
North Grafton, Massachusetts 01581, US, PERPER, Stuart J., 10 Partridge Trail
Bellingham, Massachusetts 02019, US | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/496 (2006.01) , A61P 37/00 (2006.01) | Title | FREMGANGSMÅDER TIL BEHANDLING VED ANVENDELSE AF SELEKTI-VE BCL-2-HÆMMERE | Int. application no. | US2011061769 | Int. publication no. | WO2012071374 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|